Experience

• 

  Athena Diagnostics, Inc.

  • United States
  • Hospitals and Health Care
  • 100 - 200 Employee

  • Vice President of Marketing

    • Jan 2005 - Present

    Responsible for all aspects of marketing, forecasting, and strategic planning for this reference laboratory business, focused on esoteric testing for neurological, endocrinology and nephrology disorders. Achieved annual revenue and EBITA growth of over 20%. Launched over 60 new neurology tests, delivering substantial new cumulative revenues which contributed to the double digit revenue and profit growth. Launched initiatives to expand the company into testing for Endocrine disorders. Negotiated a collaboration agreement with Baylor College of Medicine to market CGH arrays for detection of chromosomal anomalies. Lead product managers and sales management to implement market segmentation projects on major lines and consolidated a line of genetic tests for Nephrological disorders to revitalize the business segment. Developed new communication tools profiling patient co-pay responsibilities for tests not covered under healthcare insurance programs, resulting in broader acceptance of the program by both patients and physician practices. Worked with other members of the Executive Management Team to develop and execute strategies that ultimately led to the acquisition of the Company by Fisher Scientific, Inc. and subsequent integration into Thermo Fisher Scientific, Inc.Athena's expertise includes diagnosis in the areas of: peripheral nerve disorders, neurogenetic disorders, Alzheimer’s disease, paraneoplastic syndromes, movement disorders, neuromuscular disorders, ataxia, diabetes, adrenal and bone disorders, nephrotic syndromes and PKD. Athena's technologies are licensed predominantly from the academic research environment and represent our commitment to cutting-edge technology and our close relationships with world-renowned experts in the genetics of these disorders. Athena performs over 200 assays for neurological diseases using a variety of sophisticated laboratory methods.

  • Vice President of Marketing

    • 2005 - Present

• 

  Targeted Diagnostics & Therapeutics, Inc.

  • Vice President of Marketing and Business Development

    • Jan 2000 - Dec 2004

    Responsible for developing and implementing the business infrastructure required to commercialize cancer diagnostic technologies developed by this unique biotechnology development company. Responsible for business planning, market research, product development, and sales and marketing to support the launch of two colorectal cancer diagnostic tests, world-wide. TDT emerged as a leader in the development of innovative molecular diagnostics and therapeutics to improve the quality of life of patients with colorectal cancer and gastrointestinal malignancies. TDT has developed highly specific tests to detect colorectal cancer cells in lymph nodes from patients who have undergone surgical staging for colorectal cancer. The information derived from this test can assist physicians in making decisions about the administration of chemotherapy to improve disease-free survival. A similar test has been developed for the detection of circulating colorectal cancer cells in blood for post-operative surveillance for recurrent colorectal cancer.

• 

  GenTrak, Inc

  • President and CEO

    • 1996 - 2000

    Developed and Implemented a value-based turn-around strategy for this manufacter of serological and molecular phenotyping assays used for solid organ and bone marrow transplant procedures.

• 

  ActiMed Laboratories, Inc.

  • Vice President of Marketing and Sales

    • 1992 - 1996

    Responsible for sales, marketing, and strategic planning for venture-backed start-up medical products company marketing quantitative, non-instrumented device technology for measuring lipid fractions.

• 

  Colgate Palmolive

  • Vice President of Marketing at the Kendall Company (Division of Colgate Palmolive, Inc.)

    • 1972 - 1992

    Advanced from consumer brand marketing assignments within Colgate divisions in New York to VP of Marketing in Kendall, Colgate's wholly-owned healthcare subsidiary. In final assignment as V.P. Marketing at Kendall-Futuro, consolidated two business units and increased revenues from $37 Million to $118 Million in 4-years, while tripling earnings.